This kit is used for genotyping human CYP2D6*10 from genomic DNA extracted from patients' peripheral blood. The CYP2D6 gene is involved in the metabolism of about 25% of drugs (e.g. antipsychotics, antidepressants, analgesics, antiarrhythmics, etc.). People carrying CYP2D6*10 have reduced drug metabolizing enzyme activity, which can lead to drug accumulation in the body. The test results can provide guidance for personalized clinical treatment.
Product Advantages
1、Recommended by the clinical guidelines
2、High accuracy: having a unique internal reference design
3、Easy to use and fast turn-around
2、High accuracy: having a unique internal reference design
3、Easy to use and fast turn-around
Target group
1、People considering the use of anti-psychotic/depressant drugs for psychosis, depression, etc.
2、People with heart failure, coronary artery disease, arrhythmias, etc. who need beta blockers
2、People with heart failure, coronary artery disease, arrhythmias, etc. who need beta blockers
